Cellectar BiosciencesCLRB
13F holders, Q1 2026 (March 31)19holders −1
1new positions
4sold out
$2.62avg. 13F price*
At the end of Q1 2026, 19 institutions reported holding Cellectar Biosciences Inc. (CLRB) in their 13F filings, down 1 from Q4 2025. 1 opened new positions and 4 sold out. The largest holders were Bleichroeder LP ($254K), Vanguard Capital Management LLC ($208K) and Geode Capital Management, LLC ($134K).
- Company
- Cellectar Biosciences Inc.
- CUSIP
- 15117F880
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $25 |
| Exits | 4 | $206K |
All 13F filers, Q4 2025 → Q1 2026: 31,201 shares bought and 77,219 shares sold, net −46,018 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 19 holders
| Bleichroeder LP | 0.04% | No change | 100,000 | $254K |
| Vanguard Capital Management LLC | 0.00% | — | 81,884 | $208K |
| Geode Capital Management, LLC | 0.00% | Add +84.3% | 52,778 | $134K |
| Riverview Capital Advisers, LLC | 0.02% | No change | 10,384 | $50K |
| Sequoia Financial Advisors, LLC | 0.00% | Reduce -25.6% | 18,850 | $48K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 16,573 | $42K |
| Warberg Asset Management LLC | 0.07% | No change | 13,900 | $35K |
| UBS Group AG | 0.00% | Add +271.3% | 9,647 | $25K |
| BlackRock, Inc. | 0.00% | No change | 4,745 | $12K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -56.7% | 793 | $2K |
| Vanguard Global Advisers, LLC | 0.00% | — | 563 | $1K |
| Morgan Stanley | 0.00% | No change | 510 | $1K |
| TD Waterhouse Canada Inc. | 0.00% | No change | 63 | $154 |
| SBI Securities Co., Ltd. | 0.00% | No change | 11 | $28 |
| FMR LLC | 0.00% | New | 10 | $25 |
| US Bancorp \de | 0.00% | No change | 3 | $8 |
| Jones Financial Companies LLLP | 0.00% | No change | 3 | $8 |
| Danske Bank A/S | 0.00% | No change | 2 | $5 |
| Osaic Holdings, Inc. | 0.00% | Reduce -85.7% | 1 | $2 |
"% of holder's portfolio" is CLRB's weight in each manager's 13F, not the share of Cellectar Biosciences Inc. the manager owns.